CA Stock MarketDetailed Quotes
GWS Xtacy Therapeutics Corp
- 0.045
- 0.0000.00%
15min DelayMarket Closed Sep 25 16:00 ET
2.21MMarket Cap-2250P/E (TTM)
0.000High0.000Low0Volume0.000Open0.045Pre Close0.00Turnover0.05052wk High0.00%Turnover Ratio49.21MShares0.04552wk Low-0.02EPS TTM1.95MFloat Cap67.500Historical HighLossP/E (Static)43.32MShs Float0.038Historical Low-0.05EPS LYR0.00%Amplitude--Dividend TTM-3.75P/B1Lot Size--Div YieldTTM
Xtacy Therapeutics Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | (Q3)Jun 30, 2022 | (Q2)Mar 31, 2022 | (Q1)Dec 31, 2021 | (FY)Sep 30, 2021 | (Q4)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 2.78K | 634.35%1.92K | 156.53%1.92K | 76.39%2.67K | 9.46%1.66K | 0 | 262 | 750 | 1.51K | 1.51K |
| Gross profit | -2.78K | -634.35%-1.92K | -156.53%-1.92K | -76.39%-2.67K | -9.46%-1.66K | 0 | -262 | -750 | -101.48%-1.51K | -1.51K |
| Operating expense | -47.10%395.51K | 105.23%261.27K | -39.89%148.72K | -64.55%1.38M | -90.49%252.58K | 2.30%747.72K | -54.12%127.31K | 51.42%247.41K | 457.06%3.88M | 584.48%2.66M |
| Selling and administrative expenses | -46.85%370.06K | 112.74%237.54K | -30.44%136.36K | -67.36%1.24M | -91.00%237.74K | -3.02%696.22K | -52.07%111.66K | 21.74%196.03K | 465.01%3.8M | 568.30%2.64M |
| -Selling and marketing expense | --0 | --0 | ---- | 114.12%482.5K | --180K | 10.95%250K | --52.5K | ---- | --225.34K | --0 |
| -General and administrative expense | -17.07%370.06K | 301.54%237.54K | -30.44%136.36K | -78.79%759.14K | -97.81%57.74K | -9.41%446.22K | -74.60%59.16K | 21.74%196.03K | 431.54%3.58M | 568.30%2.64M |
| Other operating expenses | -50.58%25.45K | 51.63%23.73K | -75.94%12.36K | 79.05%133.37K | 1.49%14.84K | 296.88%51.5K | -64.86%15.65K | 2,074.35%51.38K | 224.19%74.49K | 302.79%14.62K |
| Operating profit | 46.73%-398.29K | -106.32%-263.19K | 39.29%-150.64K | 64.50%-1.38M | 90.43%-254.23K | -2.30%-747.72K | 54.02%-127.57K | -51.88%-248.16K | -552.78%-3.88M | -630.45%-2.66M |
| Net non-operating interest income (expenses) | 0 | 23.85%-578 | -45.03%-554 | -22.34%-1.92K | 10.67%-385 | -3.39%-397 | -94.62%-759 | -4.37%-382 | 19.44%-1.57K | 20.33%-431 |
| Total other finance cost | ---- | -23.85%578 | 45.03%554 | 22.34%1.92K | -10.67%385 | 3.39%397 | 94.62%759 | 4.37%382 | -19.44%1.57K | -20.33%431 |
| Other net income (expenses) | 35.78K | 80.91%-358 | 99.20%-1.4K | -96.35%10.87K | -15.27%162.76K | 87.23%-1.88K | -175K | 138.28%298.05K | 123.30%192.08K | |
| Gain on sale of security | ---- | 54.80%-358 | ---1.4K | 18.75%-559 | 173.87%246 | ---- | -5,992.31%-792 | ---- | -54.26%-688 | 47.48%-333 |
| Special income (charges) | --35.78K | --0 | --0 | -96.18%11.43K | --162.51K | --0 | ---1.08K | ---175K | 135.23%298.74K | ---- |
| -Less:Other special charges | ---35.78K | ---- | ---- | 96.18%-11.43K | ---162.51K | ---- | --1.08K | --175K | -978.25%-298.74K | ---- |
| Income before tax | 51.54%-362.52K | -102.86%-264.13K | 63.97%-152.6K | 61.81%-1.37M | 96.28%-91.86K | -22.52%-748.12K | 55.49%-130.2K | -158.64%-423.54K | -160.65%-3.58M | -107.45%-2.47M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 51.54%-362.52K | -102.86%-264.13K | 63.97%-152.6K | 61.81%-1.37M | 96.28%-91.86K | -22.52%-748.12K | 55.49%-130.2K | -158.64%-423.54K | -160.65%-3.58M | -107.45%-2.47M |
| Net income continuous operations | 51.54%-362.52K | -102.86%-264.13K | 63.97%-152.6K | 61.81%-1.37M | 96.28%-91.86K | -22.52%-748.12K | 55.49%-130.2K | -158.64%-423.54K | -160.65%-3.58M | -107.45%-2.47M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 51.54%-362.52K | -102.86%-264.13K | 63.97%-152.6K | 61.81%-1.37M | 96.28%-91.86K | -22.52%-748.12K | 55.49%-130.2K | -158.64%-423.54K | -160.65%-3.58M | -107.45%-2.47M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 51.54%-362.52K | -102.86%-264.13K | 63.97%-152.6K | 61.81%-1.37M | 96.28%-91.86K | -22.52%-748.12K | 55.49%-130.2K | -158.64%-423.54K | -160.65%-3.58M | -107.45%-2.47M |
| Diluted earnings per share | 66.67%-0.01 | 0.00%-0.01 | 79.69%-0.0041 | 78.26%-0.05 | 0 | 25.00%-0.03 | 50.00%-0.01 | -100.00%-0.02 | -130.00%-0.23 | -77.78%-0.16 |
| Basic earnings per share | 66.67%-0.01 | 0.00%-0.01 | 79.69%-0.0041 | 78.26%-0.05 | 0 | 25.00%-0.03 | 50.00%-0.01 | -100.00%-0.02 | -130.00%-0.23 | -77.78%-0.16 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data